Download PowerPoint

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Analgesics and hypnotics
(APA Cambridge 20. June 2013
Tom G. Hansen, MD, PhD,
Department of Anaesthesia & Intensive Care
Odense University Hospital
& University of Southern Denmark
DENMARK
Email: [email protected]
Topics covered
• Some news about old drugs
• Something about a new drug
• Focus: neonates and infants
• Focus: outcome, safety and
toxicity
Propofol, neonates and
haemodynamics
Demographics
Haemodynamics
NIRS
Authors’ conclusions
Endpoints?
• Biomarkers for CNS injury (Neuron-specific enolase
(NSE) and s-100β protein (t=0 h, after CPB, 6 h, 24 h,
48 h)
• Inflammatory mediators
• Bayley Scales of Infant Development, 2nd Ed (BSIDII) before and 2-3 w after surgery
• MRI with spectroscopy (MRS) just before surgery
and just before hospital discharge (n=5): N-acetyl
aspartate (NAA), creatine (Cr) and
glutamate/glutamine sum
• NIRS < 24 h
NSE and CRP
Conclusions
Dexmedetomidine
(2 adrenergic agonist)
Dexmedetomedine
(Mason & Lerman Anesth Analg 2011)
Licenced for PICU  OR+sedation (resp)
Problems: PK/PD
Infants & neonates?
slow onset/prolonged duration
indication?
haemodynamics (BP↓↑,HR↓)
premedication?
drug synergism?
Dexmedetomidine attenuates isofluraneinduced neuroapoptosis
Sanders et al. Acta Anaesthesiol Scand
2010
Sanders et al. Anesthesiology 2009
(Caspase 3-activation↓)
Context sensitive half times of opioids
Ideal opioid for neonates and infants?
Tolerance and hyperalgesia?
NICU/PICU?
MAC↓  Neurotoxcicity?
NEOPAIN (Anand et al Lancet 2004; 363: 1673-82)
RCT, 16 centers: IPPV treated preterm infants, Morphine group
(MG; n=449) and placebo group (PG; n=449)
Intervention: preemptive morphine in IPPV
LD 0.1 mg/kg, followed by CI 10 g/kg/h (GA 23-26)
20 g/kg/h (GA 27-29)
30 g/kg/h (GA 30-32)
+ open label morphine (OLM) for both groups
Composite primary outcome: Death, IVH and PVL
Results: Analgesia  but similar rates of deaths, IVH and PVL
- OLM  ↑CO and ↑severe IVH in MG vs. PG
+ OLM  ↑CO in PG
+OLM  IVH in MG
Long term outcome
Long term outcome
The original Dutch studies (2000-2002)
Simons et al. JAMA 2003; 290: 2419-27
Simons et al. Arch Dis Child Fetal Neonatal Ed
2005; 90: F36-40
Simons et al. Arch Dis Child Fetal Neonatal Ed
2006; 91: F46-51
Placebo-controlled RCT (n=150) in preterms on
IPPV receiving morphine: LD 0.1 mg/kg CI 10 g/kg/h
+open label morphine: LD 0.05 mg/kg, CI 5-10 g/kg/h
IVH  in morphine group, but similar analgesia and
neurological outcome
Conclusions
• Carefull dosing of anaesthetics and analgesics
in very premature infants
• Impact of haemodynamics on anaesthesiainduced neurotoxicity?
• Normal blood pressure?
• How do we treat hypotension?
Related documents